Legumain (LGMN) may serve as both a potential oncogenic marker and a
molecular target for treatment of cancer especially for personalized
medicine. Although recent findings have shed light on the functional
roles and expression patterns of LGMN, further investigations are still
warranted to elucidate the exact role and underlying mechanism of action
for LGMN in cancer.
LGMN, or asparaginyl endopeptidase, is a newly identified lysosomal cysteine protease. It was recently found to be over-expressed in tumor microenvironment , an enclosed environment that facilitates the interaction among the human solid tumors, tumor-associated endothelial and stromal cells, as well as in tumor-associated macrophages.
LGMN, or asparaginyl endopeptidase, is a newly identified lysosomal cysteine protease. It was recently found to be over-expressed in tumor microenvironment , an enclosed environment that facilitates the interaction among the human solid tumors, tumor-associated endothelial and stromal cells, as well as in tumor-associated macrophages.
These non-malignant cells support the growth of the tumors, metastasis and the survival of tumors. One of the identified key biomarkers driving the complexity of tumor microenvironment is LGMN. LGMN is a robust acidic cysteine endopeptidase with remarkably restricted specificity for hydrolysis of asparaginyl bonds.
‘Targeting legumain (LGMN) directly or utilizing LGMN as a prodrug activator are promising strategies for cancer management in the future.’
Since LGMN has been implicated in tumor development and can potentially be developed into both diagnostic and therapeutic markers. This review aims to relate the recent findings on the biology of LGMN in cancers, to the therapeutic advancements in targeting LGMN in human cancers.
Recent discoveries have also demonstrated that targeting LGMN directly or utilizing LGMN as a prodrug activator are promising strategies for cancer management in the future. However, further research is necessary before such therapeutic strategies can be fully realized.
Source: Eurekalert
- << Communicating More Effectively and Demonstrating More Empat...
- Silver Ion-Releasing Scaffolds to Treat MRSA Bone Infection >>
Recommended Reading
Dietary Phenols Could Play a Role in Cancer Treatment
Plant phenols obtained from the diet could play a role in the prevention and treatment of cancers.
Over-the-counter Heartburn Meds Could Worsen Cancer Treatment
Medications for heartburn and gastric issues could lower possibility of survival and recovery for cancer patients.
Novel Implant Identifies Suitable Drug for Individualized Cancer Treatment
The implant shows activity of each drug on the tumor and indicates drugs that will work best on the cancer as a whole.
Patient Navigation may Lead to Better Breast Cancer Treatment in High-Risk Women
The linking of a newly diagnosed cancer patient with a professional trained in assisting patients though the complex journey of cancer diagnosis and treatment, may lead to better breast cancer care in high risk and minority women.
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most common lifestyle habits that cause chronic diseases such as obesity, hypertension, diabetes mellitus, cancer and cardiovascular disease.
Health Benefits of Dandelion Plant
What is dandelion? Dandelion greens are nutrition powerhouses with a wide range of health benefits. Dandelion prevents cancer and heart attack, aids in weight loss, and improves digestion. Read this article to find out more about the benefits of dandelion.
